The Effect of Non-invasive Spinal Cord Stimulation on Anorectal Function in Individuals With Spinal Cord Injury: A Case Series

Spinal cord injury (SCI) is a devastating condition that impacts multiple organ systems. Neurogenic bowel dysfunction (NBD) frequently occurs after a SCI leading to reduced sensation of bowel fullness and bowel movement often leading to constipation or fecal incontinence. Spinal Neuromodulation has...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in neuroscience Vol. 16; p. 816106
Main Authors Kreydin, Evgeniy, Zhong, Hui, Lavrov, Igor, Edgerton, V Reggie, Gad, Parag
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 17.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Spinal cord injury (SCI) is a devastating condition that impacts multiple organ systems. Neurogenic bowel dysfunction (NBD) frequently occurs after a SCI leading to reduced sensation of bowel fullness and bowel movement often leading to constipation or fecal incontinence. Spinal Neuromodulation has been proven to be a successful modality to improve sensorimotor and autonomic function in patients with spinal cord injuries. The pilot data presented here represents the first demonstration of using spinal neuromodulation to activate the anorectal regions of patients with spinal cord injuries and the acute and chronic effects of stimulation. We observed that spinal stimulation induces contractions as well as changes in sensation and pressure profiles along the length of the anorectal region. In addition, we present a case report of a patient with a SCI and the beneficial effect of spinal neuromodulation on the patient's bowel program.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Arun Sridhar, Independent Researcher, Milton Keynes, United Kingdom
This article was submitted to Autonomic Neuroscience, a section of the journal Frontiers in Neuroscience
Reviewed by: Victor Pikov, Medipace Inc., United States; Robert A. Gaunt, University of Pittsburgh, United States
ISSN:1662-4548
1662-453X
1662-453X
DOI:10.3389/fnins.2022.816106